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Early childhood risk factors 
for rhinoconjunctivitis in adolescence: a 
prospective birth cohort study
Elisabeth Soegaard Christiansen1,2* , Henrik Fomsgaard Kjaer1, Esben Eller1, Carsten Bindslev‑Jensen1, 
Arne Høst2, Charlotte Gotthard Mortz1 and Susanne Halken2
Abstract 
Background: Rhinoconjunctivitis is a global health problem and one of the most common chronic conditions in 
children. Development of rhinoconjunctivitis depends on both genetic and environmental factors. Many studies have 
investigated rhinoconjunctivitis, but only few studies have evaluated the risk factors for non‑allergic rhinoconjuncti‑
vitis in children finding family history of atopic diseases and gender to be of importance. The aim of this study was to 
investigate possible risk factors in early life for rhinoconjunctivitis, allergic as well as non‑allergic, in adolescence.
Methods: The children in the Danish Allergy Research Center cohort were examined eight times from birth to 
14 years of age. Visits included questionnaire‑based interview, clinical examination, skin prick test and specific IgE. We 
used univariate and multivariate logistic regression to investigate the relationship between early‑life risk factors and 
the development of rhinoconjunctivitis, allergic as well as non‑allergic, in adolescence.
Results: Follow‑up rate at 14‑years was 66.2%. The prevalence of rhinoconjunctivitis was 32.8%. Family history of 
atopic diseases (aOR 2.25), atopic dermatitis (aOR 3.24), food allergy (aOR 3.89), early sensitization to inhalant and food 
allergens (aOR 2.92 and aOR 3.13) and male gender (aOR 1.90) were associated with allergic rhinoconjunctivitis but 
not with non‑allergic rhinoconjunctivitis. Early environmental tobacco exposure was inversely associated with rhino‑
conjunctivitis (aOR 0.42), allergic (aOR 0.47) as well as non‑allergic (aOR 0.43).
Conclusion: Different patterns of associations were revealed when stratifying rhinoconjunctivitis in allergic and non‑
allergic suggesting that allergic rhinoconjunctivitis and non‑allergic‑rhinoconjunctivitis are different phenotypes.
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Background
Rhinoconjunctivitis (RC) is a global health problem and 
one of the most common chronic conditions in children 
[1] with a prevalence that is still increasing [2]. When 
symptoms occur as a result of exposure to an allergen 
to which the individual is sensitized, the term allergic-
rhinoconjunctivitis is used, but few longitudinal studies 
have used the combination of symptoms and measure-
ment of sIgE [3].
Development of RC including allergic RC depends on 
both genetic and environmental factors [4]. Studies have 
indicated that gender [5, 6], family atopy [2, 4–6], early 
sensitization [4, 7, 8], food allergy [9] and atopic derma-
titis [4, 9] are risk factors for subsequent development 
of rhinoconjunctivitis. The association between breast-
feeding [2, 5], having pets [10], early exposure to tobacco 
smoke [2, 11, 12], social class [4], early wheeze [13], obe-
sity [14], older sibling(s) [15–17] and allergic RC in ado-
lescence is more contradictory.
Only a few studies have evaluated the prevalence [3, 18] 
and risk factors [17, 19] for non-allergic RC in children 
and they found family history of atopic diseases and gen-
der to be of importance.
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The Danish Allergy Research Center (DARC) cohort is 
a prospective birth cohort study with 6 follow-up exami-
nations during the first 3 years of life and further two at 6 
and 14 years. This gives a unique opportunity to explore 
risk factors in early childhood for the development of 
RC in adolescence. The aim of this study is to investigate 
possible risk factors in early life for RC, allergic as well as 
non-allergic, in adolescence.
Methods
Study population
The DARC cohort is a prospective non-interventional 
birth cohort study comprising 562 of 1095 consecutively 
enrolled full-term children born in the first two weeks 
of each month at Odense University Hospital, Denmark 
from November 1998 to November 1999. The children 
were evaluated during the first month of life and follow-
up investigations were performed at 3, 6, 12, 18 months 
and 3, 6 and 14 years of age. All visits included question-
naire-based interviews, clinical examination, skin prick 
test (SPT), specific IgE (s-IgE), and at 6 and 14 years also 
spirometry. A detailed description was published previ-
ously [18].
Diagnostic criteria
Rhinoconjunctivitis (RC) at 14  years was defined as: At 
least two separate episodes in the previous 12  months 
with one or more of the following symptoms: sneezing, 
runny, blocked nose, or itchy, red, watery eyes apart from 
a upper airway infection.
Allergic rhinoconjunctivitis (allergic RC) at 
14  years was defined as having symptoms of RC and 
s-IgE  ≥  0.35  kU/l (ImmunoCAP, Thermo Fisher Scien-
tific, Sweden) and/or a positive SPT (ALK-ABELLO, 
Copenhagen, Denmark) with a mean wheal diameter 
≥3  mm larger than the negative control to at least one 
of the inhalant allergens: grass, birch, mugwort, horse, 
dog, cat, Dermatophagoides pteronyssinus, Dermatopha-
goides farinae, Cladosporium herbarum and Alternaria 
alternata.
Non-allergic rhinoconjunctivitis (non-allergic 
RC) at 14  years was defined as symptoms of RC and 
s-IgE ≤ 0.35 kU/l and a negative SPT.
Sensitization up to 3  years of age was measured by 
s-IgE ≥ 1.43 SU/ml, as analyzed with Magic Lite (ALK-
ABELLÓ, Denmark) to the inhalant or food allergens 
(Table 1). Also a higher cut off value with s-IgE ≥ 4.0 SU/
ml (Magic Lite) was investigated. S-IgE measured by 
Magic Lite ≥1.43 and ≥4.0 SU/ml corresponds to Immu-
noCAP ≥0.35 and ≥0.70 kU/l, respectively [20].
Statistical methods
Risk factors are described and defined in Table 1.
Crude and adjusted effect estimates were analyzed with 
(multiple) logistic regression and given as crude odds 
ratio (cOR) and adjusted odds ratio (aOR) with 95% con-
fidence interval (95% CI). P values ≤0.05 were considered 
significant.
Based on knowledge from the literature the variables 
gender, family history (FH), early sensitization, food 
allergy (FA) and atopic dermatitis (AD) were identified as 
risk factors [4, 5, 7, 9, 13] for developing RC and aller-
gic RC and included in the multiple logistic regression 
model without further analysis. Gender [17] and FH [17, 
19] were identified as risk factors for non-allergic RC and 
therefore included in this model without further analysis.
All other potential risk factors in Table  1 were tested 
individually with RC, allergic RC and non-allergic RC 
using univariate logistic regression analysis and included 
in the final model for RC, allergic RC and non-allergic RC 
if P value was <0.10.
Table 1 Potential risk factors for  rhinoconjunctivitis (RC), 
allergic RC and non-allergic RC, at 14 years
a One of both parents with atopic disease
b Elevated s-IgE (Magic Lite, ALK Abello) for one or more of the inhalant 
allergens grass, birch, mugwort, horse, cat, dog, Dermatophagoides 
pteronyssinus, Dermatophagoides farinae, Alternaria alternata or Cladosporium 
herbarum antibodies at one or more visits up to 3 years
c Elevated s-IgE (Magic Lite, ALK Abello) for one or more of the food allergens 
cow’s milk, hen’s egg, wheat, peanut, codfish, shrimp or soy at one or more visits 
up to 3 years
d Food allergy (FA) was diagnosed by controlled elimination/challenge 
procedures with a positive oral food challenge (DBPCFC or OCFC) according to 
EAACI guidelines [28]
e Based on the Hanifin-Rajka criteria [29]
f Classified according to the grouping system of the Danish social research 
institute class 1–5 [30] 1–2 were considered “high”, 3–5 “low”
Risk factors 0–3 years Reference
Gender, boys Girls
Family history of atopic diseases at baselinea (FH) No FH
Early sensitization to inhalant allergensb No sensitization
Early sensitization to food allergensc No sensitization
Food allergyd (FA) No FA
Atopic dermatitise (AD) No AD
Early wheeze: at least two episodes of wheezing No wheeze
Elevated cord blood IgE ≥ 0.3 kU/l (CB‑IgE) CB IgE < 0.3 kU/l
Daily exposure to tobacco smoke from parents or oth‑
ers in the household at more than two visits (ETS)
No ETS
Maternal tobacco smoking in pregnancy No ETS in utero
Cat and/or dog keeping (pets) No pets
Exclusive breastfeeding ≥3 months (eBF) eBF ≤ 3 months
Social classf High
Overweight at 3 years (BMI girls ≤17.6 and boys 
≤17.8) [27]
No overweight
Cesarean section No section
Older siblings (siblings) No older siblings
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Correlation between risk factors were tested using Spear-
man’s correlation coefficients and negligible correlation 
was found (r ≤ 0.3) except between the variables maternal 
smoke in pregnancy and exposure to tobacco smoke (ETS) 
where the correlation was moderate (r = 0.34). Therefore, 
all variables were retained for further analysis.
All analyses were performed using STATA/SE (Stata 
Corporation, College Station, TX, USA).
Results
A total of 372 (66.2%) of the initial cohort (n = 562) com-
pleted the 14-years investigation, of whom 353 partici-
pated in at least 6 study visits. Flow-chart is presented in 
Fig. 1. Of the 190 not participating in the 14-years follow-
up investigation significant less were in social class 1–2 
and significantly more had mothers who smoked dur-
ing pregnancy and at birth. A detailed description of the 
14 years follow-up investigation was reported earlier [21].
At 14  years 32.8% (122/372) had RC, 22.3% (83/372) 
had allergic-RC and 10.2% (38/372) non-allergic-RC, 
the proportion of children with persistent symptoms 
were equally distributed in those having allergic-RC as 
well as non-allergic-RC but more with allergic-RC used 
antiallergic treatment (Table  2). One had neither SPT 
performed or s-IgE measured and therefore could not 
be classified as allergic or non-allergic (Fig. 1). A total of 
46.8% (174/372) had FH, 54.8% (204/372) had early sen-
sitization to foods, mostly to cow’s milk, egg and wheat, 
while 30.4% (113/372) had early sensitization to inhal-
ant allergens. A total of 4.8% (18/372) had verified FA 
and 23.4% (87/372) had AD. As many as 29.6% (110/372) 
were exposed to tobacco smoke (ETS) during pregnancy 
and 51.6% (192/372) up to the age of 3 (Table 3).
Crude odds estimates for all risk factors are giving in 
Table 3.
RC and allergic RC
FH and AD up to 3 years of age were associated with RC 
and allergic RC in adolescence as well as early sensitiza-
tion to inhalant and food allergens with s-IgE ≥ 4.00 SU/
ml (Magic Lite corresponding to 0.7  kU/l by Immuno-
Cap). ETS was associated with a lower prevalence of RC 
and allergic RC (Table 4).
We found no association between early wheeze, mater-
nal smoking in pregnancy, pets, breastfeeding, elevated 
CB-IgE, social class, overweight at 3 years, cesarean sec-
tion and RC and allergic RC in adolescence.
An association between male gender, FA and sibling 
were only found in those with allergic RC (Table 4).
Non‑allergic RC
Among the 38 children with non-allergic RC no asso-
ciation with FH, early sensitization to inhalant and food 
allergens, FA, and AD was found, while ETS was signifi-
cantly associated with less non-allergic RC in adolescence 
(Table 4).
Discussion
In this study, different patterns of associations were 
revealed by stratifying RC in allergic and non-allergic. It 
appears that atopic heredity and early atopic manifesta-
tions are important for the development of allergic RC 
in adolescence but less important for the development 
of non-allergic RC. Furthermore, early ETS was inversely 
Fig. 1 Flow‑chart of the DARC cohort and the distribution of rhino‑
conjunctivitis (RC) in the 14 years follow‑up investigation. Reference 
group was no RC. *One participant with RC had neither SPT nor IgE 
measured therefore could not be categorized as allergic or non‑
allergic
Table 2 Symptoms score and  use of  medication in  those 
with symptoms of allergic and non-allergic RC
Allergic RC 
% (n)
Non‑allergic RC 
% (n)
Allergic symptoms at least 1 h daily for at 
least 2 weeks from eyes and nose
37.4 (31) 36.8 (14)
Use of oral antihistamines 12.1 (52) 23.7 (9)
Use of nasal sodium cromoglicate 27.7 (23) 5.2 (2)
Use of intranasal corticosteroids 25.3 (21) 10.5 (4)
Use of other antiallergic medication 10.8 (9) 5.2 (2)
Use of any of the above medication 68.7 (57) 39.5 (15)
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Table 3 Crude effect estimates for the associations between risk factor in early childhood and RC, allergic RC and non-
allergic RC at 14 years of age
a Total number of children with data included in the analysis
* P ≤ 0.05
RC Allergic RC Non‑allergic RC
Totala Yes/no cOR (CI 95%) Totala Yes/no cOR (CI 95%) Totala Yes/no cOR (CI 95%)
Gender 1.53 (0.99–2.36) 2.33 (1.39–3.91)* 0.65 (0.32–1.33)
 Boys (n = 178) 67/111 165 54/111 124 13/111
 Girls (n = 194) 55/139 168 29/149 164 25/139
FH (n = 174) 372 72/102 2.09 (1.35–3.25)* 333 52/102 2.43 (1.46–4.06)* 288 19/102 1.45 (0.73–2.88)
Early sensitization to inhalant allergens 
(n = 113)
372 47/66 1.75 (1.10–2.77)* 333 37/66 2.24 (1.34–3.76)* 288 10/66 1.00 (0.46–2.16)
Early sensitization to foods (n = 204) 372 80/124 1.94 (1.24–3.03)* 333 56/124 2.11 (1.25–3.55)* 288 24/124 1.74 (0.86–3.52)
s‑IgE > 4.00 SU/ml to inhalant aller‑
gens (n = 56)
372 31/25 3.07 (1.72–5.48)* 333 28/25 4.58 (2.48–8.47)* 288
s‑IgE > 4.00 SU/ml to food allergens 
(n = 57)
372 34/23 3.81 (2.12–6.84)* 333 30/23 5.59 (3.01–10.39)* 288
FA (n = 18) 372 14/4 7.97 (2.57–24.78)* 333 12/4 10.39 (3.25–36.22)* 288 2/4 3.42 (0.60–19.33)
AD (n = 87) 372 48/39 3.51 (2.13–5.78)* 333 41/39 5.28 (3.05–9.15)* 288 7/39 1.22 (0.50–2.97)
Early wheeze (n = 59) 372 23/36 1.38 (0.78–2.45) 333 17/36 1.53 (0.81–2.90) 288 6/36 1.12 (0.44–2.86)
CB IgE 0.3 (n = 62) 301 22/40 1.11 (0.62–2.00) 268 18/40 1.44 (0.76–2.73) 232 3/40 0.41 (0.12–1.43)
ETS (n = 192) 372 47/145 0.45 (0.29–0.71)* 333 34/145 0.50 (0.30–0.83)* 288 13/145 0.38 (0.18–0.77)*
Maternal tobacco smoking in preg‑
nancy (n = 110)
372 30/80 0.69 (0.42–1.13) 333 24/80 0.86 (0.50–1.49)* 288 6/80 0.40 (0.16–0.99)*
Breast feed (n = 247) 362 78/169 0.76 (0.48–1.21) 323 51/169 0.67 (0.40–1.13) 277 26/169 0.99 (0.46–2.11)
Pets (n = 231) 372 75/156 0.96 (0.62–1.50) 333 52/156 1.01 (0.61–1.69) 288 22/156 0.83 (0.41–1.66)
Social class (n = 305) 372 99/206 0.92 (0.53–1.61) 333 64/206 0.72 (0.39–1.32) 288 34/206 1.82 (0.61–5.38)
Overweight at 3 years (n = 25) 320 8/17 0.86 (0.36–2.07) 285 3/17 0.46 (0.13–1.60) 243 5/17 1.87 (0.64–5.45)
Cesarean section (n = 44) 365 18/26 1.53 (0.80–2.92) 327 11/26 1.38 (0.65–2.93) 285 7/26 1.92 (0.77–4.79)
Older siblings (n = 182) 372 51/131 0.65 (0.42–1.01) 333 32/131 0.57 (0.34–0.94)* 288 19/131 0.91 (0.46–1.80)
Table 4 Adjusted effect estimates (aOR CI 95%) for associations with RC, allergic RC and non-allergic RC at 14 years of age
NI not included due to univariate logistic regression analysis
* P ≤ 0.05
RC RC inc. 
s‑IgE ≥ 4.00 SU/ml
Allergic RC Allergic RC inc 
s‑IgE ≥ 4.00 SU/ml
Non‑allergic RC
aOR (CI 95%) aOR (CI 95%) aOR (CI 95%) aOR (CI 95%) aOR (CI 95%)
Gender 1.26 (0.78–2.04) 1.30 (0.80–2.12) 1.90 (1.06–3.41)* 2.08 (1.14–3.81)* 0.64 (0.31–1.32)
FH 2.01 (1.25–3.23)* 2.01 (1.24–3.26)* 2.25 (1.27–3.99)* 2.32 (1.28–4.18)* 1.45 (0.72–2.92)
Early sensitization to inhalant 
allergens
1.31 (0.78–2.20) 1.65 (0.91–3.02) NI
Early sensitization to foods 1.62 (0.99–2.67)* 1.57 (0.86–2.87) NI
s‑IgE ≥ 4.00 SU/ml to inhalant 
allergens
2.03 (1.06–3.90)* 2.92 (1.43–5.96)* NI
s‑IgE ≥ 4.00 SU/ml to food 
allergens
2.38 (1.15–4.93)* 3.13 (1.41–6.95)* NI
FA 3.49 (1.00–12.16) 2.36 (0.62–8.92) 3.89 (1.08–14.08)* 2.08 (0.52–8.31) NI
AD 2.44 (1.37–4.33)* 2.11 (1.17–3.81)* 3.24 (1.72–6.12)* 2.68 (1.38–5.19)* NI
ETS 0.42 (0.26–0.69)* 0.42 (0.26–0.69)* 0.47 (0.26–0.83)* 0.48 (0.27–0.87)* 0.43 (0.20–0.92)*
Maternal tobacco smoking in 
pregnancy
NI NI NI NI 0.56 (0.21–1.46)
Older siblings 0.64 (0.40–1.03) 0.66 (0.41–1.07) 0.53 (0.30–0.94)* 0.55 (0.31–1.00)
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associated with RC (aOR 0.42), allergic-RC (aOR 0.47) 
and non-allergic RC (aOR 0.43), in adolescence.
Family atopy (FH) was associated with allergic RC (aOR 
2.25). The relation between FH and the development of 
rhinitis are well established in cohort studies [2, 4, 5, 9, 
19]. Some argue that maternal atopy are more important 
than paternal atopy [22], but in the MAAS (Manches-
ter Asthma and Allergy Study) study [2] both maternal 
asthma (OR 2.38) and paternal hayfever (OR 1.96) were 
significantly associated with RC at age 5. Having two par-
ents with allergy was associated with allergic rhinitis at 
13 years in the MAS (Multi-center Allergy Study) study 
[5] (OR 3.1) as was parental isolated hay fever with aller-
gic rhinitis at 8  years in the Swedish BAMSE (Children 
Allergy Milieu Stockholm study) study [19] (OR 2.2), 
whereas parental isolated asthma or eczema was not. 
Our study did not have the sufficient power to differenti-
ate between the different parental atopic diseases.
Food allergy (FA) was associated with allergic RC in 
adolescence (aOR 3.89). Among those participating at 
14  years of age, 54.8% were sensitized to food allergens 
early but only 4.8% had verified FA up to 3 years, which 
may reflect the transient and often benign nature of food 
sensitization in infancy [8]. The association between food 
allergy in infancy and RC in adolescence is less investi-
gated. In the Isle of Wight cohort an increased risk of 
nasal symptoms in those with FA at 1 and 4  years was 
found in the univariate analysis but this association dis-
appeared in the multivariate analysis [9]. Using a higher 
cut-off value both early sensitization to inhalant aller-
gens and foods reach significance, while the association 
between FA and allergic RC disappeared. This probably 
reflects sensitization in those with FA. Thus, weak sensi-
tization to food and inhalant allergens in early life might 
be less important as a risk factor for subsequent develop-
ment of allergic RC.
No association was found between FH, early sensi-
tization to inhalant allergens or foods, AD and FA and 
non-allergic RC. Though analyzed in another way (time-
to-event analysis) the same patterns were found in the 
German MAS study [7] while other studies of non-aller-
gic RC found an association between FH and non-allergic 
RC [17, 19]. An explanation of the different patterns of 
association seen in the two diseases might be that aller-
gic RC and non-allergic RC are different phenotypes with 
non-allergic RC not being driven by atopy but environ-
mental factors. Another explanation might be that the 
children with non-allergic RC had milder symptoms and 
therefore may outgrow RC.
AD was in our study associated with both RC (aOR 
2.44) and allergic-RC (aOR 3.24). Of 87 children that had 
AD up to 3 years, 48 developed RC in adolescence. Thus 
these children might follow a trajectory of the atopic 
march, whereas in two English cohort studies MAAS and 
ALSPAC (Avon Longitudinal Study of Parents and Chil-
dren) [23] only a small proportion of children followed 
trajectory profiles similar to the atopic march.
In our study boys had a higher risk of allergic-RC in 
adolescence (aOR 1.90). A consistent male predominance 
in the prevalence of allergic rhinitis was seen in all ages in 
the German MAS cohort but only in those with allergic 
parents [5]. In the Isle of Wight cohort a male predomi-
nance was seen at 18 years in those with allergic rhinitis 
[6] while there was female predominance in non-aller-
gic-rhinitis. Though not reaching statistical significance 
a tendency to female predominance in those with non-
allergic RC was found in our study.
We found that having older siblings were inversely 
associated with allergic-RC (aOR 0.53). The relation 
between large family size and less hayfever was described 
by Strachan in 1989 [16] and summarized in the “hygiene 
hypothesis” [16] suggesting that allergic diseases were 
prevented by infections in early childhood transmitted by 
contact with older siblings. Other cohort studies report 
similar associations, the German MAS cohort [5] for 
allergic rhinitis and the Tucson cohort [24] for asthma. 
Though studies of the association between having older 
siblings and the development of RC are fairly consistent 
in the conclusions of the possible beneficial effect [5, 16] 
we found such an association for allergic RC, but not for 
non-allergic RC.
ETS before the age of 3 was inversely associated with 
RC (aOR 0.42), allergic-RC (aOR 0.47) and non-aller-
gic RC (aOR 0.43) in adolescence. The same tendency 
was seen between maternal smoking during pregnancy 
and non-allergic RC though not reaching statistical sig-
nificance. The inverse association between ETS and RC, 
allergic as well as non-allergic RC could be due to bias in 
different ways, firstly as report-bias, secondly that parents 
with atopy smoked less than parents without atopy and 
thirdly as a disease-related modification of exposure [25] 
if parents to symptomatic children quit smoking. Firstly, 
all follow-up investigations included measurement of 
parental expiratory carbon monoxide as an objective 
measurement of smoking which could enhance parents 
to report smoking more accurately. Secondly, ETS was 
reported in 51.6%, and 29.6% of the mothers smoked 
during pregnancy. Parental atopy at baseline was found 
in 46.8 and 46% of those reported smoking. Thirdly, par-
ents to those developing allergic diseases are prone to 
stop smoking and among parents to children with atopic 
dermatitis and/or wheeze before 3  years only 24% were 
smokers at the 14 years follow-up. This indicates a pos-
sible reverse causation and that not only smoking expo-
sure in early life, but also the long-lasting exposure was 
important. Another Danish study [12] found the same 
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tendency with an inverse association for prenatal smoke 
exposure OR 0.8 and hayfever in adolescence and a large 
ISAAC study [11] found an inconsistent or weak associa-
tion between ETS and RC. An explanation of a possible 
beneficial effect of ETS on RC could be an immunomod-
ulatory effects of nicotine, which also indicates a possible 
beneficial effect of smoking in some inflammatory and 
neurodegenerative diseases [26].
Strengths and limitations
Our study has several limitations. First of all our study 
population are relative small and since the study included 
only 51.3% of those fulfilling the inclusion criteria, there 
is a risk for selection bias. However, this group did not 
differ from those that declined participation originally 
[18]. Participants at 14 years belonged to a higher social 
class and were less exposed to maternal smoking during 
pregnancy and birth, which may influence the prevalence 
of atopic diseases. Besides, participants in a cohort study 
may have increased awareness of atopic diseases result-
ing in an overestimation of the prevalence and on the 
other hand in avoidance of possible risk factors, which 
may result in lowering the prevalence. Despite of this we 
found a high prevalence of RC in adolescence which was 
in line with finding of other cohorts [6, 23]. In our study 
we used symptoms within the last 12 months and diag-
nosis of RC by a doctor and sensitization was determined 
both by SPT and measurement of s-IgE.
Of the 372 children participating at 14 years of age, 353 
attended at least 6 follow-up investigations. The DARC 
cohort had 6 study visits in the first 3 years which allow 
us to compensate for missing data from 1 or more vis-
its. Most of the environmental risk factors were only 
included if these were present at two visits or more, e.g. 
ETS, to validate the outcome.
Conclusion
In this study we used a widely used model to estimate the 
association between early-life risk factors and RC. Differ-
ent patterns of association were revealed when stratify-
ing RC in allergic and non-allergic suggesting that allergic 
RC and non-allergic RC are different phenotypes. Early 
sensitization is a risk factor for developing allergic RC 
in adolescence and a higher cut-off value of s-IgE seems 
associated with a higher risk.
Non-allergic RC is not driven by atopic heredity or 
early atopic manifestations but possibly by other mecha-
nism to intrinsic or environmental factors.
In the future it appears important to explore the nature 
and clinical characteristics and course of non-allergic-RC 
in order to find optimal treatment options.
Furthermore the pattern of early sensitization to spe-
cific allergens and the relation to later atopic diseases 
seem important to investigate focusing on possible pre-
ventive measures.
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